Dinara R. Nabiullina

Dinara R. Nabiullina

Auto-generated profile, based on publicly available information

Dinara R. Nabiullina

A. I. Yevdokimov Moscow State Medical and Dental University; Moscow Centre for HIV/AIDS Prevention and Treatment of Moscow Healthcare Department

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2019 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
AMA.I. Mazus
A.I. Mazus
MNM.V. Nagibina
M.V. Nagibina
AVA.S. Verbilova
A.S. Verbilova
TBT.P. Bessarab
T.P. Bessarab
ESE.M. Serebryakov
E.M. Serebryakov
APA.V. Patran
A.V. Patran
Облако Mail.Ru - это ваше персональное надежное хранилище в интернете. Все нужные файлы всегда под рукой, доступны в любой точке мира с компьютера или смартфона.

1 January 2024 in Infectious diseases: News, Opinions, Training
Verified
Journal Article
Open access
NSN.A. Smirnov
N.A. Smirnov
MNM.V. Nagibina
M.V. Nagibina
NMN.N. Martynova
N.N. Martynova
TBT.P. Bessarab
T.P. Bessarab
DND.R. Nabiullina
D.R. Nabiullina
Структура причин летальных исходов у больных ВИЧ-инфекцией на госпитальном этапе в стационарах Москвы с 2015 по 2019 г.

30 December 2021 in Лечащий врач
Verified
Journal Article
Closed access
MNM.V. Nagibina
M.V. Nagibina
AMA.I. Mazus
A.I. Mazus
NSN.A. Smirnov
N.A. Smirnov
TBT.P. Bessarab
T.P. Bessarab
NMN.N. Martynova
N.N. Martynova
DND.R. Nabiullina
D.R. Nabiullina
In this article, leishmaniasis is considered in the context of HIV infection, in which this disease appears to be an opportunistic. A general characteristic of leishmaniasis is given, and the features of the course of infection in immunodeficiency are also presented. In the example of clinical cases, issues featuring diagnostics and treatment of leishmaniasis are reviewed, the mortality rate of which remains quite high. The accession of Crimea to Russia, the high prevalence of HIV infection in the world, as well as the annually increasing tourist flow to endemic countries, require physicians of all specialties to be aware of this disease. HIV patients deserve special attention, there are already a number of reports that people with HIV are diagnosed with visceral leishmaniasis and are at greater risk of infection than the general population. The manifestations of visceral leishmaniasis among patients with immunodeficiency, as a rule, do not differ from the classical course, however, depending on the degree of suppression of immunity, the disease can take on atypical forms, which complicates timely diagnosis and the appointment of adequate therapy. If the patient has HIV infection, prolonged fever of the wrong type, enlarged lymph nodes, spleen, liver, weight loss > 10%, progressive anemia, neutropenia, thrombocytopenia, hypoalbuminemia and data on stay in regions endemic for leishmaniasis, it is advisable to be tested for visceral leishmaniasis – puncture of bone marrow with staining of smears according to Romanovsky – Giemsa, staging of PCR punctate using a test system for leishmaniasis, and if positive results are obtained, the appointment of pentavalent antimony drugs, second-line drugs – amphotericin B, liposomal amphotericin B or paromomycin.

15 May 2021 in Epidemiology and Infectious Diseases
Verified
Journal Article
Open access
PDF file
DNDinara R. Nabiullina
Dinara R. Nabiullina
AMAlexey I. Mazus
Alexey I. Mazus
NLNatalya G. Litvinova
Natalya G. Litvinova
AKAgunda A. Khamatova
Agunda A. Khamatova
MNMargarita V. Nagibina
Margarita V. Nagibina
ВФВлацкая Юлия Федоровна
Влацкая Юлия Федоровна
The article presents an analysis of a special clinical case: a male patient with perinatal HIV infection and the development of HIV multi-resistance to antiretroviral drugs. Multiple corrections of treatment regimens were carried out based on the results of determining HIV resistance to the antiretroviral drugs used. The treatment regimen included antiretroviral drugs with fundamentally new mechanisms of action for HIV, not registered in the Russian Federation. However, to date, in the patient with more than twenty years of experience in antiretroviral therapy, it has not been possible to achieve immunological and virological efficacy of treatment. There continues to be a persistent decrease in the indicators of the immune status and an increase in the viral load of HIV in the blood, the appearance of clinical symptoms of opportunistic diseases indicating the progression of HIV infection and an unfavorable vital prognosis, despite the use of various combinations of antiretroviral drugs. This observation demonstrates the difficulties in choosing an effective antiretroviral therapy, taking into account the established sensitivity of HIV to antiretroviral drugs and the possibility of their progredient administration. It is certainly necessary to analyze all ART regimens with the results of HIV resistance to antiretroviral drugs using to improve the effectiveness of therapy is in each case.